Pinned
Research from the Ethics and Public Policy Center (EPPC) revealed that 1 in 10 women experience a serious adverse event after using the abortion pill mifepristone—22 times the rate the FDA currently acknowledges. We are pleased the FDA has taken our work seriously and decided to








